Moving compliant packs between EU member states
e.g., Greece
Parallel Importer
e.g., Germany
A closer look at the regulatory and operational steps
Parallel Import involves moving authorized medicines from one EU member state (Source Market) to another (Target Market) where the product is also authorized. Because the packaging and language requirements differ, the product must be repackaged or relabeled.
The economic and regulatory logic behind the process
Parallel traders buy medicines in countries where prices are lower (e.g., Greece, Spain) and sell them in countries where prices are higher (e.g., Germany, Scandinavia). This is within the EU Single Market (Free Movement of Goods).
Since the original pack is in Greek or Spanish, it cannot be sold to a German patient. The importer must repackage or relabel the box with German text and a German Patient Information Leaflet (PIL).
Before repackaging, the Parallel Importer must verify and decommission the unique identifier of the original pack in the source market system.
Reason: "Checked-out"
The Parallel Importer acts as the Manufacturer (OBP) for the new pack. They must upload the new unique identifier data to the EU Hub.
Destination: Target Market
Information may be outdated. Always consult official documentation from EMVO, EMA, GS1, and national regulatory bodies for current requirements.